Acute stroke therapy: translating preclinical neuroprotection to therapeutic reality.
Parsons
A A
AA
SmithKline Beecham Pharmaceuticals, Neuroscience Research, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK. Andrew_A_Parsons@sbphrd.com
Irving
E A
EA
Legos
J J
JJ
Lenhard
S C
SC
Chandra
S
S
Schaeffer
T R
TR
Haimbach
R E
RE
White
R F
RF
Hunter
A J
AJ
Barone
F C
FC
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D018696:Neuroprotective Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
D018696:Neuroprotective Agents